Clinical ResearchCoronary Artery DiseaseMeta-Analysis of Cardiovascular Outcomes Trials Comparing Intensive Versus Moderate Statin Therapy
Coronary Artery Disease
Under an Elsevier user license
open archive
Abbreviations and Acronyms
A-to-Z
Aggrastat-to-Zocor trial
ACS
acute coronary syndrome
CI
confidence interval
CTT
Cholesterol Treatment Trialists
IDEAL
Incremental Decrease in End Points Through Aggressive Lipid-Lowering trial
LDL
low-density lipoprotein
MI
myocardial infarction
NCEP
National Cholesterol Education Program
OR
odds ratio
PROVE IT–TIMI-22
Pravastatin or Atorvastatin Evaluation and Infection Therapy–Thrombolysis In Myocardial Infarction-22 trial
TNT
Treating to New Targets trial
Cited by (0)
The PROVE IT–TIMI-22 trial was sponsored by Bristol-Myers Squibb and Sankyo Co. LTD, and the A-to-Z trial was sponsored by Merck. Dr. Cannon currently receives research grant support from Merck, AstraZeneca, and Schering-Plough, and serves on advisory boards and/or is a consultant to AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Schering-Plough, Pfizer, and Sanofi-Aventis. Mr. Steinberg is a research fellow supported by The Stanley J. Sarnoff Endowment for Cardiovascular Science, Inc., Great Falls, Virginia. Dr. Braunwald receives research grant support from Bristol-Myers Squibb, Merck, Pfizer, and Schering-Plough.
Copyright © 2006 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.